Identification of novel protein/DNA interactions within the promoter of the bone‐related transcription factor Runx2/Cbfa1
- 1 January 2002
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 86 (2) , 403-412
- https://doi.org/10.1002/jcb.10238
Abstract
The runt homology transcription factor Runx2/Cbfa1 is essential for bone development and osteoblast differentiation. Regulatory mechanisms that govern Runx2 transcription in osteoblasts define the osteogenic pathways that control skeletal development. In this study, we systematically examined transcription factor binding within the upstream Runx2 P1 promoter, which regulates expression of the bone-related Runx2 factor. We identified two novel protein/DNA interactions that are mediated by sequence specific factors, based on cross-competition experiments, point mutations, and gel-shift immunoassays. One complex recognizes a non-canonical Runx2 site, whereas the other factor binds to a palindromic sequence. Site-directed mutagenesis of the novel Runx2 motif (5′TCCCAC3′) within the 0.6 kb rat Runx2 promoter reduces transcription by 2-fold, indicating that this site supports enhancement of Runx2 promoter activity. Mutation of the palindromic motif (5′AGTACT3′) results in a 2–3-fold activation of the Runx2 promoter, demonstrating that the wild type sequence contributes to transcriptional repression. These studies, together with our previous findings of auto-suppression of the Runx2 promoter and negative regulation by 1,25(OH)2 Vitamin D3, suggest that physiological control of Runx2 gene expression is mediated by a series of intricate regulatory mechanisms. J. Cell. Biochem. 86: 403–412, 2002.Keywords
This publication has 33 references indexed in Scilit:
- The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2Published by Elsevier ,2005
- 1,25-(OH)2-Vitamin D3 Suppresses the Bone-Related Runx2/Cbfa1 Gene PromoterExperimental Cell Research, 2002
- Physical Interaction of the Activator Protein-1 Factors c-Fos and c-Jun with Cbfa1 for Collagenase-3 Promoter ActivationJournal of Biological Chemistry, 2002
- Expression of the Osteoblast Differentiation Factor RUNX2 (Cbfa1/AML3/Pebp2αA) Is Inhibited by Tumor Necrosis Factor-αJournal of Biological Chemistry, 2002
- Differentiation of Human Marrow Stromal Precursor Cells: Bone Morphogenetic Protein-2 Increases OSF2/CBFA1, Enhances Osteoblast Commitment, and Inhibits Late Adipocyte MaturationJournal of Bone and Mineral Research, 1999
- CBFa(AML/PEBP2)-related elements in the TGF-β type I receptor promoter and expression with osteoblast differentiationJournal of Cellular Biochemistry, 1998
- Expression of the PEBP2αA/AML3/CBFA1 Gene is Regulated by BMP4/7 Heterodimer and Its Overexpression Suppresses Type I Collagen and Osteocalcin Gene Expression in Osteoblastic and Nonosteoblastic Mesenchymal CellsBone, 1998
- Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D- responsive elements of the osteocalcin and osteopontin genesMolecular Endocrinology, 1996
- The Tissue-Specific Nuclear Matrix Protein, NMP-2, Is a Member of the AML/PEBP2/Runt Domain Transcription Factor Family: Interactions with the Osteocalcin Gene PromoterBiochemistry, 1995
- Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro.The Journal of cell biology, 1991